Takeda posts Phase 1 results for fazirsiran in subjects with hepatic impairmentNov 16Trial updateTakeda Pharmaceutical Co Ltd
FDA grants accelerated approval to ponatinib combination for Ph+ ALLNov 12Regulatory decisionponatinibTakeda Pharmaceutical Co Ltd
Takeda's Phase 3 zasocitinib trial in biologic-naive PsA patients updates as not recruitingNov 12Trial updateTakeda Pharmaceutical Co Ltd
Takeda sees ixazomib combo results posted; zasocitinib Phase 2 vitiligo trial activeNov 6Weekly roundup, 4 itemsBristol Myers Squibbixazomib
Protagonist reports MIMRYLO FDA approval, Q3 2026 results, PN-881 Phase 2b planNov 5Quarterly updatePN-881Protagonist Therapeutics, Inc.
Takeda registers observational RETRACE study on real-world narcolepsy type 1 treatment patternsOct 29Trial updateTakeda Pharmaceutical Co Ltd
Takeda's dazostinag Phase 1/2 trial completes with results; ixazomib HIV study still not recruitingOct 22Weekly roundup, 2 itemsixazomibTakeda Pharmaceutical Co LtdUpdated
Takeda gets two mesalamine label approvals; psoriatic arthritis trial still not recruitingOct 14Weekly roundup, 3 itemsmesalamineTakeda Pharmaceutical Co LtdUpdated
Takeda posts Phase 2 TAK-101 celiac results; registers two observational studiesOct 9Weekly roundup, 3 itemsTakeda Pharmaceutical Co LtdUpdated
Takeda posts results for TAK-881 vs HYQVIA pharmacokinetic study in PIDD patientsSep 30Trial updateTakeda Pharmaceutical Co Ltd
Takeda terminates GDX012 AML trial by sponsor decision; results postedSep 25Trial updateTakeda Pharmaceutical Co Ltd
Takeda's GATTEX gets REMS-related supplement approved by FDAAug 26Regulatory decisionTakeda Pharmaceutical Co Ltdteduglutide
Takeda gets FDA labeling approvals for Actoplus Met and KazanoAug 11Weekly roundup, 2 itemsalogliptin and metformin hydrochloridepioglitazone and metformin hydrochloride
Takeda registers Phase 3b trial of zasocitinib for palmoplantar psoriasisAug 7Trial updateTakeda Pharmaceutical Co Ltd
FDA approves Takeda's Orzeyful for new molecular entity applicationAug 5Regulatory decisionoveporextonTakeda Pharmaceutical Co Ltd